Year archive

Shaperon Inc. — 2025 filings

All 34 regulatory filings released by Shaperon Inc. (378800) in 2025, sourced directly from the official regulator.

34 Filings

2025 Period

2025 filings (34)

Filing	Released	Lang
증권발행결과(자율공시) (주주배정 유상증자) Regulatory Filings	2025-11-11	Korean
증권발행실적보고서 Regulatory Filings	2025-11-11	Korean
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정) Regulatory Filings	2025-11-05	Korean
유상증자최종발행가액확정 (주주배정후 실권주 일반공모) Regulatory Filings	2025-10-30	Korean
[기재정정]투자설명서 Regulatory Filings	2025-10-30	Korean
[기재정정]주요사항보고서(유상증자결정) Regulatory Filings	2025-10-30	Korean
[발행조건확정]증권신고서(지분증권) Regulatory Filings	2025-10-30	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Regulatory Filings	2025-10-21	Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서 Regulatory Filings	2025-10-21	Korean
주식등의대량보유상황보고서(일반) Regulatory Filings	2025-10-20	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2025-09-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-09-16	Korean
유상증자1차발행가액결정 (주주배정후 실권주 일반공모) Share Issue/Capital Change	2025-09-16	Korean
[기재정정]주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-09-16	Korean
[발행조건확정]증권신고서(지분증권) Share Issue/Capital Change	2025-09-16	Korean
투자설명서 Capital/Financing Update	2025-09-16	Korean
권리락 (유상증자) Share Issue/Capital Change	2025-09-16	Korean
임원ㆍ주요주주특정증권등거래계획보고서 Director's Dealing	2025-09-12	Korean
[기재정정]증권신고서(지분증권) (2025.10) Capital/Financing Update	2025-09-01	Korean
주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-08-18	Korean
증권신고서(지분증권) (2025.10) Share Issue/Capital Change	2025-08-18	Korean
반기보고서 (2025.06) Interim / Quarterly Report H1 2025	2025-08-14	Korean
분기보고서 (2025.03) Interim / Quarterly Report Q1 2025	2025-05-15	Korean
[기재정정]정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2025-03-26	Korean
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2025-03-26	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2025-03-25	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2025-03-25	Korean
감사보고서제출 Audit Report / Information FY 2024	2025-03-17	Korean
사업보고서 (2024.12) Annual Report FY 2024	2025-03-17	Korean
주주총회소집공고 AGM Information	2025-03-07	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2025-03-07	Korean
주주총회소집결의 Proxy Solicitation & Information Statement	2025-03-05	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2024	2025-02-17	Korean
투자판단관련주요경영사항 (경증 또는 중등증 아토피 피부염 환자를 대상으로 HY209겔의 제2상 임상시험 Part 1 종료 및 Part 2 임상 시험 진행 승인) Regulatory Filings	2025-01-14	Korean